CatSci Appoints New Head of Customer Acquisition, Jenn Clark

Apr 12th 2022
CatSci Appoints New Head of Customer Acquisition, Jenn Clark

CatSci Ltd is incredibly proud to share that Jenn Clark will be joining the CatSci team as our Head of Customer Acquisition. Jenn’s appointment is another pivotal step in CatSci’s continued evolution; it will ensure that our capabilities are always aligned to the needs and expectations of our customers now and in the future. Jenn will act as a key communicator, both internally and externally, while bringing a fresh perspective to the CatSci team.

Jenn obtained a degree in Biomedical Sciences from Lancaster University, and has over 20 years’ of experience in the Pharmaceutical Industry, having worked within first and second line-management, business development, and direct sales. Furthermore, Jenn has held several key strategic roles in businesses recognised for customer excellence, and has had specific experience in driving partnerships with companies in both development programmes as well as commercialisation, particularly within the inhalation field. She has been a key board member in an e-retail business, and more recently for a global pharmaceutical CDMO specialist.

Jenn said: “I am delighted to be joining CatSci, as they are going from strength to strength in their evolution. There is a reason customers come to CatSci, and that’s because they have come to expect in-depth understanding of the challenges of pharmaceutical CMC development, cutting-edge science and a customer-focused attitude. I look forward to leveraging that internal talent to always align CatSci’s offering to customers’ high expectations. We all have the same vision – which is to get life-saving therapeutics to those in need – so I will be working closely with the team so that we continue to deliver value-adding outcomes to our customers, first time, every time.”

Jenn’s appointment is the latest step in our continuous evolution to offer more and better to our customers. It comes following the news that we have expanded into the Japanese market, as well as our appointment of Dr Gary Parsons as our Director of Pharmaceutical Development, and Dr Robert Crook as Director of Chemical Development. Along with Jenn, these additions to the CatSci family will strengthen and enhance not only our capabilities, but also our relations with customers as we continue our mission to be the innovation partner of choice for leading pharma companies around the world.